These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8742311)

  • 1. The maximum tolerated dose for inhalation bioassays: toxicity vs overload.
    Morrow PE; Haseman JK; Hobbs CH; Driscoll KE; Vu V; Oberdörster G
    Fundam Appl Toxicol; 1996 Feb; 29(2):155-67. PubMed ID: 8742311
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of contact site cancer potency across dose routes: case study with epichlorohydrin.
    Ginsberg GL; Pepelko WE; Goble RL; Hattis DB
    Risk Anal; 1996 Oct; 16(5):667-81. PubMed ID: 8962517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. So carcinogens have thresholds: how do we decide what exposure levels should be considered safe?
    Wilson JD
    Risk Anal; 1997 Feb; 17(1):1-3. PubMed ID: 9131822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of modifying effects of formaldehyde on carcinogenesis].
    Ianysheva NIa; Balenko NV; Chernichenko IA; Litvichenko ON; Sovertkova LS; Babiĭ VF
    Gig Sanit; 1998; (1):51-4. PubMed ID: 9560943
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk from low-dose exposures.
    Zendzian RP
    Science; 1994 Nov; 266(5188):1142-3. PubMed ID: 7973686
    [No Abstract]   [Full Text] [Related]  

  • 7. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.
    Cronin WJ; Oswald EJ; Shelley ML; Fisher JW; Flemming CD
    Risk Anal; 1995 Oct; 15(5):555-65. PubMed ID: 7501875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer risk assessment of direct acting carcinogens.
    Zito R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):273-8. PubMed ID: 10606168
    [No Abstract]   [Full Text] [Related]  

  • 12. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 13. The need for biological risk assessment in reaching decisions about carcinogens.
    Clayson DB
    Mutat Res; 1987 May; 185(3):243-69. PubMed ID: 3574332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat lung tumors induced by exposure to selected poorly soluble nonfibrous particles.
    Nikula KJ
    Inhal Toxicol; 2000; 12(1-2):97-119. PubMed ID: 10715619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk from low-dose exposures.
    Portier CJ; Lucier GW; Edler L
    Science; 1994 Nov; 266(5188):1141-2. PubMed ID: 7973685
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of carcinogenic activity in Fischer rats and B6C3F1 mice following 103-week inhalation exposures to toluene.
    Huff J
    Int J Occup Environ Health; 2003; 9(2):138-46. PubMed ID: 12848242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that toxic injury is not always associated with induction of chemical carcinogenesis.
    Tennant RW; Elwell MR; Spalding JW; Griesemer RA
    Mol Carcinog; 1991; 4(6):420-40. PubMed ID: 1793481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing cancer risks from short-term exposures in children.
    Ginsberg GL
    Risk Anal; 2003 Feb; 23(1):19-34. PubMed ID: 12635720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rall.
    Huff J
    Ann N Y Acad Sci; 2002 Dec; 982():208-30. PubMed ID: 12562639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in carcinogenicity testing: dose selection.
    Haseman JK
    Fundam Appl Toxicol; 1985 Feb; 5(1):66-78. PubMed ID: 3886467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
    Goodman G; Wilson R
    Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.